Company Filing History:
1 out of 2 
1 out of 1,743 
1 out of 99 
Years Active: 2017
Title: Fabrizio Andreelli: Innovator in Insulin Resistance Treatment
Introduction
Fabrizio Andreelli is a notable inventor based in Levallois Perret, France. He has made significant contributions to the field of medical research, particularly in the treatment of insulin resistance. His innovative work has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Fabrizio holds a patent for a composition that includes the HIP/PAP protein or its derivatives for treating insulin resistance. This invention is particularly relevant for non-insulin dependent subjects, providing a potential solution for managing this condition effectively. The patent highlights the importance of the HIP/PAP protein in medical treatments and showcases Andreelli's commitment to advancing healthcare.
Career Highlights
Throughout his career, Fabrizio has worked with prominent organizations such as Alfact Innovation and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Fabrizio has collaborated with notable professionals, including Paul Amouyal and Christophe Magnan. These partnerships have enriched his research and expanded the impact of his innovations in the medical community.
Conclusion
Fabrizio Andreelli's work in developing treatments for insulin resistance exemplifies the vital role of inventors in advancing medical science. His contributions continue to influence the field and offer hope for improved health outcomes.